8/15/2018 - Immunotherapy and Chemotherapy Combos Are the New Standard of Care for NSCLC, Says Konduri

Media Outlet: Targeted Oncology
8/15/2018- Kartik Konduri, MD, recently spoke on the treatment considerations and decisions he makes when treating patients with non–small cell lung cancer (NSCLC). Konduri, medical oncologist with Texas Oncology–Baylor Charles A. Sammons Cancer Center, explained his treatment decisions based on two case scenarios during a Targeted Oncology live case-based peer perspectives presentation.

8/1/2018 - Who Is the Oncology Nurse?

Media Outlet: U.S. News & World Report
8/1/2018- Dr. Elena Tobin, oncology nurse with Texas Oncology–Baylor Charles A. Sammons Cancer Center, discusses the relationship between nurses, oncologists, and patients, as well as the critical role of an oncology nurse in educating cancer patients on what to expect during treatment.

6/28/2018 - When Life is in the Balance, Excellence Means Everything

Media Outlet: Making the Health Care System Work
6/28/2018- The Texas Oncology-Baylor Charles A. Sammons Cancer Center has collaborated with the adjoining Baylor T. Boone Pickens Cancer Hospital to develop a “center of excellence” for adult bone marrow transplants. The health care institution has established a concentration of clinical expertise and assembled interdisciplinary teams to deliver comprehensive care around a specific condition or procedure.

6/28/2018 - FDA Reviewing Treatment for Aggressive Prostate Cancer

Media Outlet: KXAS-TV (NBC, Dallas-Fort Worth)
6/28/2018- The FDA is reviewing approval of enzalutamide, a drug which lowered the risk of metastasis or death in men with non-metastatic hormone-resistant prostate cancer, according to a new study of 1,400 patients. Dr. Ashley Ross, medical oncologist at Texas Urology Specialists–Plano, discusses the trial. 

6/18/2018 - Cancer Research and Right to Try

Media Outlet: KDFW-TV (FOX, Dallas)
6/18/2018- Stage IV lung cancer patient Rebecca Hill discusses the clinical trial that saved her life, thanks to Dr. Katherine Wang, medical oncologist at Texas Oncology-Presbyterian Cancer Center Dallas. Dr. Debra Patt, medical oncologist at Texas Oncology–Austin Central, advocates for treatments under a clear research protocol or that have demonstrated efficacy and safety under the FDA.

6/18/2018 - Amid News That Others Like It Have Struggled, DFW’s Lone Proton Therapy Center Says It’s Viable, Wit

Media Outlet: D CEO Healthcare
6/18/2018- Nearly three years after its first treatment, Texas Center for Proton Therapy has administered proton beam therapy to 1,000 people - a rate that’s kept the $105 million facility financially viable, even as it seeks to take on higher volumes moving forward. Dr. Andrew Lee, medical director for the center, discusses the benefit of having proton therapy available to patients in the Dallas-Fort Worth area.

6/15/2018 - Barriers to Patient Access to CAR-T Therapy in the Community Setting

Media Outlet: Journal of Clinical Pathways
6/15/2018- Journal of Clinical Pathways spoke with Dr. Houston Holmes of Texas Oncology–Baylor Charles A. Sammons Cancer Center about the utility and accessibility of chimeric antigen receptor (CAR) T-cell therapies for patients with hematologic malignancies in the community setting. Dr. Holmes explained the toxicities associated with these therapies and how the next generation of products aim to decrease such toxicities.

6/14/2018 - The Particle Therapy Co-Operative Group (PTCOG) Conference

6/14/2018- The Particle Therapy Co-Operative Group (PTCOG) conference is an event that takes place in North America once every four years where field experts are invited to give educational lectures.

5/30/2018 - Texas Center for Proton Therapy Treats Its 1,000th Patient

Media Outlet: D CEO Healthcare and Irving-Las Colinas Chamber of Commerce
5/30/2018- Texas Center for Proton Therapy reached a milestone with the treatment of its 1,000th patient. The center is a collaboration between Texas Oncology, the US Oncology Network, McKesson Specialty Health, and Baylor Scott & White Health, and remains the only provider in North Texas that offers the precise form of radiation therapy.

5/21/2018 - Strong Uptake of RayStation Monte Carlo Dose Engine Among Proton Therapy Centers

Media Outlet: RaySearch Laboratories
5/21/2018- One year after RaySearch's first release of the proton MC dose engine in RayStation 6, a survey was sent out to the 18 RayStation proton sites that are in clinical operation with pencil beam scanning. The survey focused on the clinical implementation and use of the new MC dose engine, and showed that no less than 13 of the 18 clinics have implemented the MC dose engine in their clinical work flows, with remaining clinics currently in commissioning.